Log in

NASDAQ:ALECAlector Stock Price, Forecast & News

$23.43
+1.53 (+6.99 %)
(As of 04/7/2020 02:53 AM ET)
Add
Compare
Today's Range
$22.48
Now: $23.43
$23.98
50-Day Range
$21.09
MA: $26.64
$31.34
52-Week Range
$13.64
Now: $23.43
$35.93
Volume437,526 shs
Average Volume654,433 shs
Market Capitalization$1.84 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.24
Alector, Inc., a clinical stage biotechnology company, focuses on developing therapies that harness the immune system to cure neurodegenerative diseases. Its products in Phase I clinical trial include AL001, a humanized recombinant monoclonal antibody for the treatment of frontotemporal dementia; and AL002 for the treatment of Alzheimer's disease. The company's preclinical stage products comprise AL101 for the treatment of multiple neurodegenerative disorders; and AL003 for the treatment of Alzheimer's disease. It also has 10 programs under research and development stage. The company was founded in 2013 and is headquartered in South San Francisco, California.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 2.5Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 1.3 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.45 out of 5 stars


Industry, Sector and Symbol

Industry Biological products, except diagnostic
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:ALEC
CUSIPN/A
CIKN/A
Phone415-231-5660

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$21.22 million
Book Value$2.83 per share

Profitability

Net Income$-105,390,000.00
Net Margins-496.65%

Miscellaneous

Employees91
Market Cap$1.84 billion
Next Earnings Date5/11/2020 (Estimated)
OptionableNot Optionable

Receive ALEC News and Ratings via Email

Sign-up to receive the latest news and ratings for ALEC and its competitors with MarketBeat's FREE daily newsletter.


Alector (NASDAQ:ALEC) Frequently Asked Questions

How has Alector's stock been impacted by COVID-19 (Coronavirus)?

Alector's stock was trading at $24.92 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, ALEC shares have decreased by 6.0% and is now trading at $23.43. View which stocks have been mosted impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Alector?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Alector in the last year. There are currently 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Alector.

When is Alector's next earnings date?

Alector is scheduled to release its next quarterly earnings announcement on Monday, May 11th 2020. View our earnings forecast for Alector.

How were Alector's earnings last quarter?

Alector Inc (NASDAQ:ALEC) announced its earnings results on Tuesday, March, 24th. The company reported ($0.45) earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of ($0.48) by $0.03. The company earned $6 million during the quarter, compared to analysts' expectations of $9.60 million. Alector had a negative net margin of 496.65% and a negative return on equity of 45.56%. View Alector's earnings history.

What price target have analysts set for ALEC?

5 Wall Street analysts have issued 1 year price targets for Alector's stock. Their forecasts range from $28.00 to $28.00. On average, they expect Alector's stock price to reach $28.00 in the next twelve months. This suggests a possible upside of 19.5% from the stock's current price. View analysts' price targets for Alector.

Has Alector been receiving favorable news coverage?

Headlines about ALEC stock have trended very negative this week, according to InfoTrie. The research firm identifies negative and positive press coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Alector earned a news impact score of -3.3 on InfoTrie's scale. They also gave news coverage about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the stock's share price in the next several days. View the latest news aboutAlector.

Who are some of Alector's key competitors?

What other stocks do shareholders of Alector own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Alector investors own include Editas Medicine (EDIT), NVIDIA (NVDA), Cisco Systems (CSCO), Alibaba Group (BABA), Advanced Micro Devices (AMD), AT&T (T), Verizon Communications (VZ), Johnson & Johnson (JNJ), Pfizer (PFE) and Gossamer Bio (GOSS).

Who are Alector's key executives?

Alector's management team includes the following people:
  • Dr. Tillman U. Gerngross, Co-Founder & Chairman (Age 55)
  • Dr. Arnon Rosenthal, Co-Founder, CEO, Pres & Director (Age 64)
  • Dr. Robert Paul M.D., Ph.D., Chief Medical Officer (Age 51)
  • Dr. Robert S. King, Chief Devel. Officer (Age 56)
  • Dr. Asa Abeliovich M.D., Ph.D., Co-Founder

When did Alector IPO?

(ALEC) raised $177 million in an IPO on Thursday, February 7th 2019. The company issued 9,300,000 shares at $18.00-$20.00 per share. Morgan Stanley, BofA Merrill Lynch, Cowen and Barclays acted as the underwriters for the IPO.

What is Alector's stock symbol?

Alector trades on the NASDAQ under the ticker symbol "ALEC."

How do I buy shares of Alector?

Shares of ALEC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Alector's stock price today?

One share of ALEC stock can currently be purchased for approximately $23.43.

How big of a company is Alector?

Alector has a market capitalization of $1.84 billion and generates $21.22 million in revenue each year. The company earns $-105,390,000.00 in net income (profit) each year or ($1.71) on an earnings per share basis. Alector employs 91 workers across the globe. View additional information about Alector.

What is Alector's official website?

The official website for Alector is http://www.alector.com/.

How can I contact Alector?

Alector's mailing address is 131 OYSTER POINT BLVD. SUITE 600, SOUTH SAN FRANCISCO CA, 94080. The company can be reached via phone at 415-231-5660 or via email at [email protected]

This page was last updated on 4/7/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel